STOK NASDAQ
Stoke Therapeutics, Inc.
1W: -5.3%
1M: -17.3%
3M: -13.4%
YTD: -3.9%
1Y: +195.4%
3Y: +164.6%
5Y: -16.8%
$29.34
-0.33 (-1.11%)
Weekly Expected Move ±4.2%
$28
$29
$30
$31
$33
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$32M
Revenue
-83.2% YoY
$-170M
Net Income
-437.7% YoY
$-148M
Free Cash Flow
-313.4% YoY
83.2%
Gross Margin
-857.6%
Op. Margin
-802.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-58.4%
ROA-49.2%
ROIC-215.9%
Valuation
P/E-10.9
P/B4.7
EV/EBITDA-9.9
Leverage
Debt/Equity0.00
Current Ratio5.28
Interest Cov.-53.4x
Quality Scores
Piotroski F1/9
Altman Z16.36
Beneish M254.90